4 MMWR May 22, 1998b) ensuring that all school-aged children receive a second dose of MMR vaccine, <strong>and</strong>c) working with other countries to set <strong>and</strong> achieve national measles elimination goals.<strong>Rubella</strong> And Congenital <strong>Rubella</strong> Syndrome (CRS)Clinical Characteristics<strong>Rubella</strong> is an exanthematous illness characterized by nonspecific signs <strong>and</strong> symptomsincluding transient erythematous <strong>and</strong> sometimes pruritic rash, postauricular orsuboccipital lymphadenopathy, arthralgia, <strong>and</strong> low-grade fever. Clinically similar exanthematousillnesses are caused by parvovirus, adenoviruses, <strong>and</strong> enteroviruses.Moreover, 25%–50% of rubella infections are subclinical. The incubation period rangesfrom 12 to 23 days. Be<strong>for</strong>e rubella vaccine was available, the disease was commonamong children <strong>and</strong> young adults.Among adults infected with rubella, transient polyarthralgia or polyarthritis occurfrequently. These manifestations are particularly common among women (18 ). Centralnervous system complications (i.e., encephalitis) occur at a ratio of 1 per 6,000cases <strong>and</strong> are more likely to affect adults. Thrombocytopenia occurs at a ratio of 1 per3,000 cases <strong>and</strong> is more likely to affect children.The most important consequences of rubella are the miscarriages, stillbirths, fetalanomalies, <strong>and</strong> therapeutic abortions that result when rubella infection occurs duringearly pregnancy, especially during the first trimester. An estimated 20,000 cases ofCRS occurred during 1964–1965 during the last U.S. rubella epidemic be<strong>for</strong>e rubellavaccine became available.The anomalies most commonly associated with CRS are auditory (e.g., sensorineuraldeafness), ophthalmic (e.g., cataracts, microphthalmia, glaucoma, chorioretinitis),cardiac (e.g., patent ductus arteriosus, peripheral pulmonary artery stenosis, atrial orventricular septal defects), <strong>and</strong> neurologic (e.g., microcephaly, meningoencephalitis,mental retardation). In addition, infants with CRS frequently exhibit both intrauterine<strong>and</strong> postnatal growth retardation. Other conditions sometimes observed among patientswho have CRS include radiolucent bone defects, hepatosplenomegaly,thrombocytopenia, <strong>and</strong> purpuric skin lesions.Infants who are moderately or severely affected by CRS are readily recognizable atbirth, but mild CRS (e.g., slight cardiac involvement or deafness) may be detectedmonths or years after birth, or not at all. Although CRS has been estimated to occuramong 20%–25% of infants born to women who acquire rubella during the first20 weeks of pregnancy, this figure may underestimate the risk <strong>for</strong> fetal infection <strong>and</strong>birth defects. When infants born to mothers who were infected during the first8 weeks of gestation were followed <strong>for</strong> 4 years, 85% were found to be affected (19 ).The risk <strong>for</strong> any defect decreases to approximately 52% <strong>for</strong> infections that occur duringthe ninth to twelfth weeks of gestation. Infection after the twentieth week ofgestation rarely causes defects. Inapparent (subclinical) maternal rubella infection canalso cause congenital mal<strong>for</strong>mations. Fetal infection without clinical signs of CRS canoccur during any stage of pregnancy.
Vol. 47 / No. RR-8 MMWR 5<strong>Rubella</strong> EliminationBe<strong>for</strong>e rubella vaccine was licensed during 1969, rubella incidence was greatestamong preschool <strong>and</strong> elementary school children. There<strong>for</strong>e, vaccination campaignsinitially targeted children in kindergarten <strong>and</strong> the early grades of elementaryschool, with the aim of interrupting circulation of the virus <strong>and</strong> eliminating the risk <strong>for</strong>exposure among susceptible pregnant women. The risks associated with administeringa potentially teratogenic live virus vaccine to young women of childbearing agewere not known. During 1969–1976, reported rubella cases decreased from 57,600 to12,400. However, during 1975–1977, 62% of reported rubella cases occurred amongpersons aged >15 years compared with 23% of cases occurring during 1966–1968,<strong>and</strong> serologic studies suggested that 10%–15% of adults remained susceptible to rubella(20 ).The number of CRS cases reported nationwide decreased by 69% from 69 in 1970to 22 in 1976. <strong>Rubella</strong> outbreaks continued to occur among older adolescents <strong>and</strong>young adults (e.g, in military camps, high schools, colleges, <strong>and</strong> universities). In 1977,ACIP modified its recommendations to include the vaccination of susceptible postpubertalgirls <strong>and</strong> women. During the same year, the DHEW undertook the NationalChildhood Immunization Initiative, which sought to immunize >90% of the nation’schildren against all vaccine-preventable diseases. En<strong>for</strong>cement of requirements <strong>for</strong>vaccination be<strong>for</strong>e school entry was part of the initiative. The number of reported rubella<strong>and</strong> CRS cases decreased after these programs were implemented, from 20,395rubella cases <strong>and</strong> 29 CRS cases in 1977 to 752 rubella cases <strong>and</strong> 2 CRS cases in 1984.In 1988, 225 cases of rubella were reported in the United States, the fewest since nationalreporting began.However, because of outbreaks among unvaccinated adults (e.g., in prisons, colleges,<strong>and</strong> workplaces), >1000 rubella cases were reported in 1990 <strong>and</strong> again in 1991.The largest outbreak <strong>and</strong> the greatest number of CRS cases occurred among children<strong>and</strong> adults in religious communities that do not accept vaccination. Since 1992, reportedindigenous rubella <strong>and</strong> CRS have continued to occur at a low but relativelyconstant endemic level with an annual average of